About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback